Status:
COMPLETED
Cohort Study of Clopidogrel and Proton Pump Inhibitors
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
University College, London
Conditions:
Coronary Heart Disease
Acute Coronary Syndrome
Eligibility:
All Genders
Brief Summary
Patients who have experienced and survived non-ST segment elevation acute coronary syndromes are often prescribed a combination of aspirin and clopidogrel to thin the blood and prevent further acute c...
Detailed Description
Background Patients who have experienced and survived non-ST segment elevation acute coronary syndromes are often prescribed a combination of aspirin and clopidogrel to thin the blood and prevent fur...
Eligibility Criteria
Inclusion
- All patients registered in the GPRD from 1998 to date and receiving clopidogrel in combination with aspirin and with at least 12 months up to standard observation before the first prescription for clopidogrel will be eligible for inclusion
Exclusion
- Data will be restricted to 1998 onwards as this is the year clopidogrel was licensed in the UK.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
24471 Patients enrolled
Trial Details
Trial ID
NCT01231867
Start Date
December 1 2010
End Date
May 1 2012
Last Update
May 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London School of Hygiene & Tropical Medicine
London, United Kingdom, WC1E 7HT